Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE–Choroid
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.12.39 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Yinhao Wang and 7 co-authors. Institution: Department of Ophthalmology, First Affiliated Hospital, Zhejiang University School of Medicine, China. Major MEDLINE topics: Quercetin, Choroidal Neovascularization. Cited 17 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Wet AMD (wAMD) is associated with cellular senescence. However, senescent cell-targeted therapies for wAMD have rarely been comprehensively studied. This study aimed to explore the therapeutic effects of senolytic agents on choroidal neovascularization (CNV).
Methods
RNA sequencing datasets were obtained from the Gene Expression Omnibus database and used to explore the association between senescence and wAMD. We explored the effects of senescent adult RPE cell line-19 cells on the proliferation, migration, invasion, and tube formation of human umbilical vein endothelial cells. A laser-induced CNV animal model was used to study wAMD. We studied a senescent cell elimination therapy for CNV progression using two types of senolytics and a transgenic method.
Results
Cells in the retinal pigment epithelium-choroid of the CNV model were enriched in senescence, inflammation, and angiogenesis gene sets. AP20187 was used to specifically eliminate senescent cells and proven to alleviate CNV progression in INK-ATTAC transgenic mice. Senescent adult RPE cell line-1 cells produced elevated levels of senescence-associated secretory phenotypes, including VEGFs; they also demonstrated increased proliferation, migration, invasion, and tube formation in human umbilical vein endothelial cells. The number of senescent cells increased in the laser-induced CNV rat model, and intravitreal injections of dasatinib with quercetin reduced the expression of p16 in CNV and alleviated neovascularization.
Conclusions
Senescent RPE cells can accelerate pathological neovascularization; thus, senescent cell-targeting therapy has great clinical potential for wAMD.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, First Affiliated Hospital, Zhejiang University School of Medicine, China.
- Department of Ophthalmology, Peking University Third Hospital, China.
- Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China.
- Department of Biochemistry and Molecular Biology, Health Science Center, Peking University, China.
- Department of General Surgery, Peking University First Hospital, Beijing, China.
Cite
APA
Wang, Y., Tseng, Y., Chen, K., Chen, K., Chen, K., Huang, Z., Mao, Z., & Li, X. (2023). Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE–Choroid. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.12.39
Vancouver
Wang Y, Tseng Y, Chen K, Chen K, Chen K, Huang Z, et al. Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE–Choroid. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.12.39
BibTeX
@article{Wang2023,
author = {Wang, Yinhao and Tseng, Yulin and Chen, Keyu and Chen, Kuangqi and Chen, Kai and Huang, Zhihua and Mao, Zebin and Li, Xuemin},
title = {Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE–Choroid},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.12.39}
}
EUVIMED